Clinical Trials Directory

Trials / Completed

CompletedNCT00680706

Thiamine and Acute Decompensated Heart Failure: Pilot Study

Targeting Myocardial Energy Metabolism for the Treatment of Acute Heart Failure: The Effect of Thiamine on Biochemical, Electrocardiographic and Respiratory Parameters in Hospitalized Patients.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
131 (actual)
Sponsor
Baystate Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart failure remains an increasing cause of morbidity and mortality in the United States even in the face of recent advances in the treatment of cardiovascular disease. There is an urgent need to reevaluate the treatment of heart failure. Shifting substrate utilization used in energy metabolism from fatty acids to glucose is beneficial to the heart presumably by increasing the efficiency of ATP production. Several new drugs for the treatment of cardiac ischemia work by this mechanism. There is increasing evidence that patients with heart failure may also benefit by the same type of intervention. Patients with heart failure are known to have low serum thiamine levels because of poor dietary intake and increased urinary excretion. Inadequate thiamine will deleteriously shift substrate utilization from glucose to fatty acids. We hypothesize that thiamine supplementation will be beneficial for patients with heart failure by increasing glucose and decreasing fatty acid utilization. This will be initially tested in a pilot double-blinded placebo controlled study of thiamine supplementation in diabetic and non-diabetic patients presenting to the emergency department with acute decompensated heart failure.

Conditions

Interventions

TypeNameDescription
DRUGThiamineThiamine (100 mg) in 50 ml D5W, x 2.
DRUGPlaceboD5W (50 ml)

Timeline

Start date
2008-01-01
Primary completion
2010-02-01
Completion
2012-06-01
First posted
2008-05-20
Last updated
2013-08-21
Results posted
2012-09-28

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00680706. Inclusion in this directory is not an endorsement.